Obez olan ve olmayan osas’lı olgularda nötrofil lenfosit oranının önemi var mı?

Giriş: Obezite ve obezite ile ilgili hastalıklar, özellikle gelişmiş ülkelerde olmak üzere dünya çapında artmaktadır. Obstrüktif uyku apne sendromu (OUAS) ve obezite arasındaki ilişkinin bildirilmesine bağlı olarak OUAS insidansında bir artış görülmüştür. Obezite ile OUAS arasındaki etkileşimlerin yol açtığı sistemik inflamasyon, metabolik değişiklikler ve endokrin anomalilere bağlı olarak ateroskleroz ve kardiyovasküler hastalıklara yatkınlık vardır. Sistemik inflamasyon derecesini tahmin etmek için inflamatuar markerlar kullanılabilir; bunlar, metabolik riskler gibi gelecekteki advers etkiler için prognostik bir faktör olabilir. Yakın zamanda sistemik inflamasyonun bir göstergesi olarak kullanılmaya başlanan bir belirteç de nötrofil-lenfosit oranı (NLR)'dir. Amaç, obezite olan ve olmayan OUAS'lı hastalardaki sistemik inflamasyonun kolayca ölçülebilen bir parametresi olan NLR'yi değerlendirmektir. Materyal ve Metod: 155 hasta beden kitle indeksine göre dört farklı gruba ayrıldı. Her grup için lökosit, nötrofil, lenfosit, NLR değerleri ve antropometrik ölçümler karşılaştırıldı. Bulgular: Grup 4 (obez OUAS grubu)'ün NLR ve nötrofil sayıları grup 1, 2 ve 3’ ten istatistiksel olarak anlamlı derece daha yüksekti. Grup 4'ün (obez OUAS grubu) lenfosit sayıları tüm gruplar arasında en düşük olup, bu değerler grup 1 (kontrol grubu), 2 (normal ağırlık OSAS grubu) ve 3 (aşırı kilolu OSAS grubu) lenfosit sayılarına göre istatistiksel olarak anlamlı şekilde düşüktü (p< 0.001). Vücut kitle indeksi ile obez OUAS'lıların lenfosit sayıları arasında pozitif bir korelasyon vardı (r= 0.027, p= 353). Sonuç: Obezite derecesine göre NLR oranının arttığı ve bununla ilişkili olarakta inflamatuar yanıtın da arttığını görüldü. Obez OUAS'lılarda NLR bir inflamasyon belirteci olarak kullanılabilir ve bu kişiler için metabolik risklerin tahmininde faydalı olabilir.

Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?

Introduction: An increase in the incidence of OSAS (obstructive sleep apnoea syndrome) has been seen due to the reported association between OSAS and obesity. Subjects are predisposed to cardiovascular disease due to systemic inflammation caused by theinteractions between obesity and OSA. Inflammatory markers could be used to predict the degree of systemic inflammation, whichcould be a prognostic factor for future adverse events such as metabolic risks. One marker that has recently started being used as anindicator of systemic inflammation is neutrophil-to-lymphocyte ratio (NLR).Materials and Methods: The aim is to evaluate NLR, which is a easily measured parameter of systemic inflammation in OSAS subjectswith and without obesity. 155 subjects were assigned to four different groups according to their body mass indices. Comparisons ofwhite blood cell, neutrophil, lymphocyte, NLR values and anthropometric measurements were done for each group.Results: The NLR and neutrophil counts of group 4 were statistically significant and higher than those of groups 1, 2 and 3. Thelymphocyte counts of group 4 were the lowest amongst all groups,these values were lower than the lymphocyte counts of groups 1, 2 and 3 with statistically significant differences (p< 001). A positive correlation was found between the body mass index and lymphocyte count values of obese OSAS subjects (r= 0.027, p= 353).Conclusion: The NLR ratio was found to be increasing by obesity grade and reveals that the associated inflammatory response alsoincreases. The NLR ratio might be used as an inflammatory marker in obese OSAS subjects.

___

  • Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009;33:1195-205.
  • Kim J, In K, Kim J, You S, Kang K, Shim J, et al. Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am J Respir Crit Care Med 2004;170:1108- 13.
  • Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-8.
  • Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a populationbased sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001;163:685-9.
  • Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers UK. Interactions between obesity and obstructive sleep apnea. Chest 2010;137:711-9.
  • Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
  • Turkey Feed And Health Survey (preliminary study report) S.B. Turkey Public Health Agency Data (2010).
  • Tintinger GR, Pretorius L, Labadarios D. Obstructive sleep apnoea and obesity. S Afr J Clin Nutr 2001;24:174-7.
  • Zamarron C, Paz VG, Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Int Med 2008;19:390-8.
  • Medzhitov R. Origin and physiological roles of inflammation. Nature 2008;454:428-35.
  • Zahorec R. Ratio of neutrophil to lymphocyte counts– rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14.
  • Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010;184:873- 8.
  • Lee YY, Choi CH, Kim HJ, Kim TJ, Lee JW, Lee JH, et al. Pretreatment neutrophil: lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res 2012;32:1555-61.
  • Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011;107:433-8.
  • Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH Publication No. 204. Washington: U.S. Government Printing Office, 1968.
  • Iber C, Ancoli-Israel S, Chesson A, Quan S; for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
  • Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnea/hypopnea syndrome. Lancet 1994;344:653-5.
  • Williams A, Scharf SM. Obstructive sleep apnea, cardiovascular disease and inflammation-is NF-kappa B the key? Sleep Breath 2007;11:69-76.
  • Paulsen FP, Steven P, Tsokos M, Jungmann K, Müller A, Verse T, et al. Upper airway epithelial structural changes in obstructive sleep disordered breathing. Am J Respir Crit Care 2002;166:501-9.
  • Alwani A, Rubinstein I. The nose and OSA. Curr Opin Pulm Med 1998;4:361-2.
  • Rubinstein I. Nasal inflammation in patients with obstructive sleep apnea. Laryngoscope 1995;105:175-7.
  • Atmaca HU, Akbas F, Okten IN, Nuhoglu E, Inal BB. Can Neutrophil-to-Lymphocyte Ratio Serve as an Inflammatory Marker in Obesity? Istanbul Med J 2014;15:216-20.
  • Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996;45:1435-8.
  • Kjosen B, Bassoe HH, Myking O. The glucose oxidation in isolated leukocytes from female patients suffering from overweight or anorexia nervosa. Scand Clin Lab Invest 1975;35:447-54.
  • Palmblad J, Hallberg D, Engstedt L. Polymorphonuclear function after small intestinal shunt operation for morbid obesity. Br J Haematol 1980;44:101-8.
  • Palmblad J, Rossner S. Granulocyte functions during treatment of obesity. Int J Obes 1979;3:119-22.
  • Yenigun A, Karamanlı H. Investigation of the relationship between neutrophil-to lymphocyte ratio and obstructive sleep apnoea syndrome. J Laryngol Otol 2015;129:887- 92.
  • Wolk R, Somers VK. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab 2006;8:250-60.
  • Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleepdisordered breathing. JAMA 2000;284:3015-21.
  • Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, et al. Identifi cation of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003;168:522-30.
  • Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J Appl Physiol 1960;15:377-82.
  • Malhotra A, White DP. Obstructive sleep apnoea. Lancet 2002;360:237-45.
  • Phillips BG, Hisel TM, Kato M, Pesek CA, Dyken ME, Narkiewicz K, et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 1999;17:1297-300.
  • Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000;279:234-7.
  • Arbel Y, Birati EY, Shapira I, Finn T, Berliner S, Rogowski O. Comparison of different anthropometric measurements and inflammatory biomarkers. Int J Inflam 2012:124693.
  • Dogan M, Akyel A, Bilgin M, Erat M, Cimen T, Sunman H, et al. Can admission neutrophil to lymphocyte ratio predict infarct-related artery patency in ST-segment elevation myo- cardial infarction. Clin Appl Thromb Hemost 2015;21:172-6.
  • Ozbay I, Kahraman C, Balikci HH, Kucur C, Kahraman NK, Ozkaya DP, et al. Neutrophil-to-lymphocyte ratio in patients with peripheral vertigo: a prospective controlled clinical study. Am J Otolaryngol 2014;35:699-702.
Tüberküloz ve Toraks-Cover
  • ISSN: 0494-1373
  • Yayın Aralığı: 4
  • Başlangıç: 1951
  • Yayıncı: Tuba Yıldırım
Sayıdaki Diğer Makaleler

Hipoksemik solunum yetmezliği ile yoğun bakıma başvuran influenza pnömonili hastaların özellikleri

Sena ATAMAN, Cenk KIRAKLI, Özlem EDİBOĞLU

Pakistan, Hazara Bölgesinde akciğer tüberkülozu hastalarının birinci basamak tedavilerinde Mycobacterium tuberculosis ilaç direnci paterni

Hafiz Sajid AKBAR, Faheem JAN, Sadia S., Waqas AHMAD, Manzoor AHMAD, Anwar KHALID, Muhammad Taj AKBAR, Shahid WALI

Nemlendirme tedavisi; KOAH ve OUAS hastalarında uzun vadeli etkileri

Sevinç SARINÇ ULAŞLI, Antonio ESQUINAS, Dorina ESENDAĞLI

Gebelikte yabancı cisim aspirasyonu: Başarıyla çıkarılan leblebi tanesi

Barış Mustafa POYRAZ, Ayşegül ALKILIÇ, Numan NUMANOĞLU, Servet Seçkin Tunç KASAP, Gökhan TULUNAY, Murat ÖZKAN

Immuno-checkpoint inhibitor-associated hyper-eosinophilia and tumor shrinkage

Hiroaki SATOH, Shijima TAGUCHI, Hajime OSAWA, Katsunori KAGOHASHI, Shinichiro OKAUCHI

Obez olan ve olmayan osas’lı olgularda nötrofil lenfosit oranının önemi var mı?

Nursel DİKMEN, Nagihan BİLAL, Fulsen BOZKUŞ, Hüseyin ARPAĞ, Anıl SAMUR, Nurhan ATİLLA

Pulmoner rehabilitasyon programını tamamlayan koah tanılı olgularda oral nütrisyonel destek; altı ay ve bir yıllık takipleri

Pınar ERGÜN, Fatma ŞENGÜL, Dicle KAYMAZ, Nurcan EGESEL, Filiz TAŞDEMİR, İpek CANDEMİR

Gebe kadınlarda parapnömonik efüzyonun yönetimi

Öner DİKENSOY, Ebru DİKENSOY, Richard W. LİGHT

Allerjik rinitli hastaların sigaraya yönelik tutumları astım ve koah hastalarından farklı mı?

Ömür AYDIN, Fatma ÇİFTÇİ, Dilşad MUNGAN, Gülfem ÇELİK, Elif ŞEN, Zeynep ÇELEBİ SÖZENER, Şadan SOYYİĞİT

Difficulty in management of pneumothorax in an octogenarian with pulmonary fibrosis

Hiroaki SATOH, Hajime OSAWA, Shinichiro OKAUCHİ